trending Market Intelligence /marketintelligence/en/news-insights/trending/RCdRfS1xm1Y08kVg07xPxw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

GHO Capital exits Caprion Biosciences

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

GHO Capital exits Caprion Biosciences

London-based specialist healthcare investment adviser GHO Capital Partners LLP, or Global Healthcare Opportunities, sold Caprion Biosciences to Arsenal Capital Partners Inc.

Caprion provides specialized flow cytometry immune monitoring and quantitative mass spectrometry proteomics services to the biopharmaceutical industry.

Arsenal is a middle-market private equity firm investing in specialty industrials and healthcare businesses.